// App-Quantinova.ai

5518 : A clinically applicable molecular-based classification for endometrial cancers.

Researchers

Presenter

  • Jessica N. McAlpine

Principal Investigators

  • Melissa McConechy

  • Lien Hoang

  • Samuel Leung

  • Quentin Nakonechny

  • Amy Lum

  • Winnie Yang

  • Cyril Blake Gilks

  • David Huntsman

  • Aline Talhouk

Medical Centers

  • University of British Columbia and BC Cancer Agency, Vancouver, BC, Canada

  • Montreal University, Montreal, QC, Canada

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • BC Cancer Agency, University of British Columbia, Vancouver, BC, Canada

  • The University of British Columbia, Vancouver, BC, Canada

  • British Columbia Cancer Agency - Centre for Translational and Applied Genomics, Vancouver, BC, Canada

  • BC Cancer Agency, Vancouver, BC, Canada

  • Vancouver Coastal Health, Vancouver, BC, Canada

  • British Columbia Cancer Agency, Vancouver, BC, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Endometrial Cancer

Biomarkers

  • p53

  • Cluster of Differentiation 206

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved